At a glance
ClinicalIndex Comparison RecordN/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Insulin, Androgen, and Risk in African-American Women
National Heart, Lung, and Blood Institute (NHLBI)·observational·Posted May 26, 2000·Updated May 13, 2016
In Brief
An observational study for Cardiovascular Diseases and 5 related conditions. Completed.
Detailed Summary
To distinguish whether the observed gender differences in plasma insulin and insulin resistance reflect biologic differences, or whether the gender differences in insulinemia are determined by greater adiposity in women. Also, to determine if the hyperinsulinemia per se contributes to excess risk for cardiovascular disease in African American women. Finally, since higher androgenicity is linked with cardiovascular risk in women, to determine if the risk factors associated with hyperinsulinemia are modulated by sex hormones.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Diabetes Mellitus, Hypertension, Heart Diseases, Hyperinsulinism, Insulin Resistance
Countries--
Collaborators--
Timeline
N/ACompletedFinished
19931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartSep 1993
Study CompletionAug 1998
First PostedMay 2000
TodayJul 2026
First PostedMay 26, 2000
Enrollment StartSep 1, 1993
Study CompletionAug 1, 1998
TodayJul 2, 2026
Posted 26.1 years ago